C-reactive protein and statins for primary prevention of coronary heart disease. A slight increase in the serum concentration of C-reactive protein (CRP) has been associated with an increased risk of coronary heart disease. The recently published and widely publicized results of the JUPITER study have confirmed the role of CRP as risk biomarker, suggesting the use of the protein determination as a means to modulate the primary prevention treatment. As a result, it is anticipated that many apparently healthy persons will ask for the CRP measurement in order to test their risk and, in case, start a statin therapy, with a consequent great increase in CRP testing. In this context clinical laboratories need to stay on top of the issues related to this biomarker, playing a key role in ensuring the test is ordered and employed correctly by focusing on its advantages and limitations

Proteina C reattiva e statine per la prevenzione primaria della coronaropatia / M. Panteghini. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - 33:3(2009), pp. 165-167.

Proteina C reattiva e statine per la prevenzione primaria della coronaropatia

M. Panteghini
Primo
2009

Abstract

C-reactive protein and statins for primary prevention of coronary heart disease. A slight increase in the serum concentration of C-reactive protein (CRP) has been associated with an increased risk of coronary heart disease. The recently published and widely publicized results of the JUPITER study have confirmed the role of CRP as risk biomarker, suggesting the use of the protein determination as a means to modulate the primary prevention treatment. As a result, it is anticipated that many apparently healthy persons will ask for the CRP measurement in order to test their risk and, in case, start a statin therapy, with a consequent great increase in CRP testing. In this context clinical laboratories need to stay on top of the issues related to this biomarker, playing a key role in ensuring the test is ordered and employed correctly by focusing on its advantages and limitations
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
2009
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/72553
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact